CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 16:00:02 2026-06-18 EDT			5-day change	1st Jan Change
185.00 ^USD	+1.46%		-1.34%	-7.26%

06-18	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise	CI
06-18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT

Insiders

05-11	Charles River Laboratories International, Inc. Announces Board Elections	CI
02-18	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-18	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
01-12	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-12	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
25-10-15	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
25-09-16	Charles River Laboratories announces chief financial officer transition	RE
25-09-16	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
25-09-16	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
25-09-16	Charles River Laboratories Says CFO to Step Down	MT
25-05-07	Charles River to add new directors, review business in agreement with Elliott	RE
25-05-07	Charles River Laboratories International, Inc. Announces Board Changes	CI
24-11-12	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
24-08-12	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
24-03-04	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
24-03-01	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT
24-01-24	Charles River Laboratories International, Inc. Appoints Reshema Kemps-Polanco to Board of Directors	CI
24-01-16	Charles River Laboratories International, Inc. Announces Executive Changes	CI
23-12-18	Charles River Laboratories International Insider Sold Shares Worth $1,243,350, According to a Recent SEC Filing	MT
23-12-01	Charles River Laboratories International Insider Sold Shares Worth $365,801, According to a Recent SEC Filing	MT